Xenocor Appoints David McNally as Chief Executive Officer, Antony Watson to Chief Commercial Officer and David Van Ness to Chief Technology Officer
Medical device industry veteran to lead expansion of Saberscope™, the market’s first and only single-use video platform for minimally invasive surgery, laparoscopic procedures, and advanced surgical visualization technologies. Xenocor announces David McNally as CEO and leadership appointments as the company... Read More →
AI-Enhanced ECG flags aortic stenosis years before symptoms featuring AccurKardia
Matthew Segar, MD, of The Texas Heart Institute, discusses new research evaluating whether AI‑enabled ECG analysis can detect aortic stenosis years before traditional symptom‑driven diagnosis. Because echocardiography is effective but not scalable for population screening, his team applied the previously... Read More →
Toro Neurovascular Announces FDA 510(k) Clearance for Toro 88 Superbore Catheter
First clinical cases successfully completed; U.S. launch to be led by Kaneka’s Neurovascular division IRVINE, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Toro Neurovascular today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the... Read More →
Vitestro Raises $70 Million in Oversubscribed Series B Financing to Advance Autonomous Robotic Phlebotomy and Commercial Readiness
Labcorp Venture Fund, Mayo Clinic, Sutter Health, InterVest, MGFO, PGGM, Puma Venture Capital, and ROM Utrecht invest alongside existing investors Invest-NL, EIC Fund, Fred Moll, NYBC Ventures, and Sonder Capital. Utrecht, The Netherlands, March 10, 2026 – Vitestro, the pioneer... Read More →
May Health Raises $11.7M to Advance its Novel Technology to Treat PCOS-related Infertility
New investor Nexpring Health™ joins existing investors, including Sofinnova, Bpifrance, and Trill Impact MENLO PARK, Calif.–(BUSINESS WIRE)–May Health, a medical device company dedicated to helping women living with polycystic ovary syndrome (PCOS), today announced that it raised €10 million ($11.7M)... Read More →
From animal models to organoids: how functional data fits regulatory expectations featuring Diagnostic Biochips
The landscape of preclinical neuroscience research is shifting. Growing ethical considerations, cost pressures, and translational limitations have accelerated interest in organoid alternatives to animal models in neuroscience. While animal models have long served as the foundation for safety and efficacy... Read More →
DeviceTalks Weekly podcast: Armor Medical’s wearable could give earlier warnings of severe hemorrhaging before it’s too late
In this episode, Armor Medical Co-founder and CEO Kelsey Mayo shares her ultimate entrepreneurial journey. Mayo recognized early on that her career needed to make an impact, but the focus of her passion became clear after a frightening experience of... Read More →
Non-Viral Cytokine-Inducible SH2 Containing ProteinLocus-Specific Integrated Fibroblast Activation ProteinAlpha-Targeting Chimeric Antigen Receptor T Cells AchievePotent Antitumor Efficacy in Glioblastoma featuring Full Circles Therapeutics
ABSTRACT Chimeric antigen receptor T (CAR-T) cells have been used to treat patients with glioblastoma (GBM) in clinical trial settings bytargeting GBM-associated antigens. However, the efficacy of these CAR-T cells remains limited mainly due to the heterogeneousexpression of tumor antigen... Read More →
Closing the Patient Support Gap: How Ankr Health’s 4X Platform Transforms Oncology Care
Patient Stories: How MedTech Innovator alumni are transforming lives At MedTech Innovator, we empower healthtech companies to bring groundbreaking solutions to patients in need. Our Patient Stories series highlights the real-world clinical impact of the companies we support—showcasing how their... Read More →
Avisi Technologies Announces $10.7M Capital Raise to Advance Novel Glaucoma Device Development
REDWOOD CITY, Calif., Feb. 25, 2026 /PRNewswire/ — Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, announces the closing of $10.7M in new financing. The Series A round was led by MedVenture Partners, with participation from... Read More →